Baker Robert A
Cardiac Surgery Research and Perfusion, Flinders Medical Centre and Flinders University, Bedford Park, South Australia, Australia.
Semin Cardiothorac Vasc Anesth. 2009 Jun;13(2):122-6. doi: 10.1177/1089253209337159. Epub 2009 Jul 17.
Hemostasis management of the cardiac surgical patient has changed following the withdrawal of aprotinin for use in cardiac surgical patients. The challenge to minimize blood loss and reduce exposure of cardiac surgical patients to blood products continues to grow with patients presenting being older and sicker and more complex procedures being performed. The cardiac surgery team has many options available for it to consider; although current recommendations strongly support the use of cell salvage as one process to assist in this challenge, other options need to be equally critically evaluated.
随着抑肽酶不再用于心脏手术患者，心脏手术患者的止血管理发生了变化。随着接受手术的患者年龄越来越大、病情越来越重、手术操作越来越复杂，将心脏手术患者的失血量降至最低并减少其对血制品的接触这一挑战也日益严峻。心脏外科团队有许多可供考虑的选择；尽管目前的建议强烈支持使用细胞回收作为应对这一挑战的一种方法，但其他选择也需要进行同样严格的评估。
